Literature DB >> 23073079

The significance of the nuclear farnesoid X receptor (FXR) in β cell function.

Martina Düfer1, Katrin Hörth, Peter Krippeit-Drews, Gisela Drews.   

Abstract

Bile acids (BAs) are important signaling molecules that are involved in the regulation of their own metabolism, lipid metabolism, energy expenditure and glucose homeostasis. The nuclear farnesoid X receptor (FXR) and the G-protein-coupled TGR-5 are the most prominent BA receptors. FXR is highly expressed in liver and activation of liver FXR profoundly affects glucose homeostasis. Strikingly, the effect of FXR activation on glucose metabolism seems to depend on the nutritional status of the organism, i.e., slimness or obesity. Recently, it became evident that FXR is present in pancreatic β cells and that activation of β cell FXR contributes to the regulation of glucose homeostasis. Interestingly, FXR activation increases glucose-induced insulin secretion by non-genomic effects on stimulus-secretion coupling. The first chapter of this review shortly introduces the role of liver FXR in glucose metabolism, the second part focuses on the impact of FXR in lean and obese animals, and the third chapter highlights the significance of FXR in β cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23073079      PMCID: PMC3524139          DOI: 10.4161/isl.22383

Source DB:  PubMed          Journal:  Islets        ISSN: 1938-2014            Impact factor:   2.694


  32 in total

1.  The bile acid sensor FXR regulates insulin transcription and secretion.

Authors:  Barbara Renga; Andrea Mencarelli; Piero Vavassori; Vincenzo Brancaleone; Stefano Fiorucci
Journal:  Biochim Biophys Acta       Date:  2010-01-07

2.  The nuclear receptor FXR is expressed in pancreatic beta-cells and protects human islets from lipotoxicity.

Authors:  Iuliana Ristea Popescu; Audrey Helleboid-Chapman; Anthony Lucas; Brigitte Vandewalle; Julie Dumont; Emmanuel Bouchaert; Bruno Derudas; Julie Kerr-Conte; Sandrine Caron; François Pattou; Bart Staels
Journal:  FEBS Lett       Date:  2010-05-04       Impact factor: 4.124

3.  Bile salt sequestration induces hepatic de novo lipogenesis through farnesoid X receptor- and liver X receptor alpha-controlled metabolic pathways in mice.

Authors:  Hilde Herrema; Maxi Meissner; Theo H van Dijk; Gemma Brufau; Renze Boverhof; Maaike H Oosterveer; Dirk-Jan Reijngoud; Michael Müller; Frans Stellaard; Albert K Groen; Folkert Kuipers
Journal:  Hepatology       Date:  2010-03       Impact factor: 17.425

4.  Conformationally constrained farnesoid X receptor (FXR) agonists: heteroaryl replacements of the naphthalene.

Authors:  Jonathan Y Bass; Justin A Caravella; Lihong Chen; Katrina L Creech; David N Deaton; Kevin P Madauss; Harry B Marr; Robert B McFadyen; Aaron B Miller; Wendy Y Mills; Frank Navas; Derek J Parks; Terrence L Smalley; Paul K Spearing; Dan Todd; Shawn P Williams; G Bruce Wisely
Journal:  Bioorg Med Chem Lett       Date:  2010-12-23       Impact factor: 2.823

5.  The farnesoid X receptor FXRalpha/NR1H4 acquired ligand specificity for bile salts late in vertebrate evolution.

Authors:  Shi-Ying Cai; Liangshi Xiong; Charles G Wray; Nazzareno Ballatori; James L Boyer
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-06-13       Impact factor: 3.619

Review 6.  Role of bile acids and bile acid receptors in metabolic regulation.

Authors:  Philippe Lefebvre; Bertrand Cariou; Fleur Lien; Folkert Kuipers; Bart Staels
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

7.  Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at?

Authors:  Xinjie Zhao; Andreas Peter; Jens Fritsche; Michaela Elcnerova; Andreas Fritsche; Hans-Ulrich Häring; Erwin D Schleicher; Guowang Xu; Rainer Lehmann
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-12-09       Impact factor: 4.310

8.  TGR5-mediated bile acid sensing controls glucose homeostasis.

Authors:  Charles Thomas; Antimo Gioiello; Lilia Noriega; Axelle Strehle; Julien Oury; Giovanni Rizzo; Antonio Macchiarulo; Hiroyasu Yamamoto; Chikage Mataki; Mark Pruzanski; Roberto Pellicciari; Johan Auwerx; Kristina Schoonjans
Journal:  Cell Metab       Date:  2009-09       Impact factor: 27.287

Review 9.  Bile acid sequestrants and the treatment of type 2 diabetes mellitus.

Authors:  Bart Staels; Folkert Kuipers
Journal:  Drugs       Date:  2007       Impact factor: 9.546

10.  Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity.

Authors:  Oded Shaham; Ru Wei; Thomas J Wang; Catherine Ricciardi; Gregory D Lewis; Ramachandran S Vasan; Steven A Carr; Ravi Thadhani; Robert E Gerszten; Vamsi K Mootha
Journal:  Mol Syst Biol       Date:  2008-08-05       Impact factor: 11.429

View more
  6 in total

Review 1.  Role of farnesoid X receptor in inflammation and resolution.

Authors:  Firdose Begum Shaik; Durbaka V R Prasad; Venkata Ramireddy Narala
Journal:  Inflamm Res       Date:  2014-11-07       Impact factor: 4.575

Review 2.  Signaling molecules involved in lipid-induced pancreatic beta-cell dysfunction.

Authors:  Shiying Shao; Yan Yang; Gang Yuan; Muxun Zhang; Xuefeng Yu
Journal:  DNA Cell Biol       Date:  2013-02       Impact factor: 3.311

3.  Helicobacter hepaticus infection promotes hepatitis and preneoplastic foci in farnesoid X receptor (FXR) deficient mice.

Authors:  Alton G Swennes; Alexander Sheh; Nicola M A Parry; Sureshkumar Muthupalani; Kvin Lertpiriyapong; Alexis García; James G Fox
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

4.  ID1 marks the tumorigenesis of pancreatic ductal adenocarcinoma in mouse and human.

Authors:  Yuanxin Tang; Sheng Zhang; Jiazi Li; Chunli Wu; Qing Fan
Journal:  Sci Rep       Date:  2022-08-08       Impact factor: 4.996

Review 5.  Coordinated Actions of FXR and LXR in Metabolism: From Pathogenesis to Pharmacological Targets for Type 2 Diabetes.

Authors:  Lin Ding; Shuguang Pang; Yongmei Sun; Yuling Tian; Li Yu; Ningning Dang
Journal:  Int J Endocrinol       Date:  2014-04-28       Impact factor: 3.257

Review 6.  Update on FXR Biology: Promising Therapeutic Target?

Authors:  Chang Yeob Han
Journal:  Int J Mol Sci       Date:  2018-07-16       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.